Furthermore, acute activation of Myc in pIns-c-MycERTAM transgenic mice initially results in highly increased serum insulin levels and subsequent hypoglycemia, whereas chronic activation of Myc in these mice leads to a significant decrease in serum insulin, resulting in hyperglycemia (29). The gene discussed is MYC; the disease is Hyperglycemia.